PhoreMost is a Cambridge UK-based biotechnology company dedicated to turning scientific breakthroughs into life-changing cancer therapies
PhoreMost is a Cambridge UK-based biotechnology company dedicated to turning scientific breakthroughs into life-changing cancer therapies. The company's lead program, PMC-001, is a differentiated orally bioavailable, CNS-penetrant microtubule disruptor positioned to treat primary and metastatic brain cancers.